Effect of dialysis modality on survival of hepatitis C-infected ESRF patients

Biplab Bose; Stephen McDonald; Carmel Hawley; Fiona Brown; S Badve; Kathryn Wiggins; Kym Bannister; Neil Boudville; Philip Clayton; David Johnson

doi:10.2215/CJN.02200311

Effect of dialysis modality on survival of hepatitis C-infected ESRF patients

Biplab Bose, Stephen McDonald, Carmel Hawley, Fiona Brown, S Badve, Kathryn Wiggins, Kym Bannister, Neil Boudville, Philip Clayton, David Johnson

Medicine Monash Health

Research output: Contribution to journal › Article › Other

9 Citations (Scopus)

Abstract

Hepatitis C virus (HCV) infection is associated with increased mortality and morbidity in end-stage renal failure (ESRF) patients. Despite a lower incidence and risk of transmission of HCV infection with peritoneal dialysis (PD), the optimal dialysis modality for HCV-infected ESRF patients is not known. The aim of this study was to evaluate the impact of dialysis modality on the survival of HCV-infected ESRF patients.

Original language	English
Pages (from-to)	2657 - 2661
Number of pages	5
Journal	Clinical Journal of the American Society of Nephrology
Volume	6
Issue number	11
DOIs	https://doi.org/10.2215/CJN.02200311
Publication status	Published - 2011

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.2215/CJN.02200311

Cite this

@article{6a0e88772a52473daca721f6d7c8753c,

title = "Effect of dialysis modality on survival of hepatitis C-infected ESRF patients",

abstract = "Hepatitis C virus (HCV) infection is associated with increased mortality and morbidity in end-stage renal failure (ESRF) patients. Despite a lower incidence and risk of transmission of HCV infection with peritoneal dialysis (PD), the optimal dialysis modality for HCV-infected ESRF patients is not known. The aim of this study was to evaluate the impact of dialysis modality on the survival of HCV-infected ESRF patients.",

author = "Biplab Bose and Stephen McDonald and Carmel Hawley and Fiona Brown and S Badve and Kathryn Wiggins and Kym Bannister and Neil Boudville and Philip Clayton and David Johnson",

year = "2011",

doi = "10.2215/CJN.02200311",

language = "English",

volume = "6",

pages = "2657 -- 2661",

journal = "Clinical Journal of the American Society of Nephrology",

issn = "1555-9041",

publisher = "American Society of Nephrology",

number = "11",

}

TY - JOUR

T1 - Effect of dialysis modality on survival of hepatitis C-infected ESRF patients

AU - Bose, Biplab

AU - McDonald, Stephen

AU - Hawley, Carmel

AU - Brown, Fiona

AU - Badve, S

AU - Wiggins, Kathryn

AU - Bannister, Kym

AU - Boudville, Neil

AU - Clayton, Philip

AU - Johnson, David

PY - 2011

Y1 - 2011

N2 - Hepatitis C virus (HCV) infection is associated with increased mortality and morbidity in end-stage renal failure (ESRF) patients. Despite a lower incidence and risk of transmission of HCV infection with peritoneal dialysis (PD), the optimal dialysis modality for HCV-infected ESRF patients is not known. The aim of this study was to evaluate the impact of dialysis modality on the survival of HCV-infected ESRF patients.

AB - Hepatitis C virus (HCV) infection is associated with increased mortality and morbidity in end-stage renal failure (ESRF) patients. Despite a lower incidence and risk of transmission of HCV infection with peritoneal dialysis (PD), the optimal dialysis modality for HCV-infected ESRF patients is not known. The aim of this study was to evaluate the impact of dialysis modality on the survival of HCV-infected ESRF patients.

UR - https://www.scopus.com/pages/publications/80655135438

U2 - 10.2215/CJN.02200311

DO - 10.2215/CJN.02200311

M3 - Article

SN - 1555-9041

VL - 6

SP - 2657

EP - 2661

JO - Clinical Journal of the American Society of Nephrology

JF - Clinical Journal of the American Society of Nephrology

IS - 11

ER -

Effect of dialysis modality on survival of hepatitis C-infected ESRF patients

Abstract

UN SDGs

Access to Document

Other files and links

Cite this